Impact Factor 4.716 | CiteScore 4.71
More on impact ›

Correction ARTICLE

Front. Immunol., 26 July 2019 | https://doi.org/10.3389/fimmu.2019.01742

Corrigendum: IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth

Rui Yang1, Lan Yao1, Ling Shen2, Wei Sha1*, Robert L. Modlin3,4, Hongbo Shen1* and Zheng W. Chen2
  • 1Shanghai Key Lab of Tuberculosis, Clinic and Research Center of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, China
  • 2Department of Microbiology and Immunology, Center for Primate Biomedical Research, University of Illinois College of Medicine, Chicago, IL, United States
  • 3Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, United States
  • 4Division of Dermatology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States

A Corrigendum on
IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth

by Yang, R., Yao, L., Shen, L., Sha, W., Modlin, R. L., Shen, H., et al. (2019). Front. Immunol. 10:913. doi: 10.3389/fimmu.2019.00913

There is an error in the Funding statement. The correct Name for the “Chinese National Major Projects” is the “National Program Project.”

There are also errors in the grant numbers in Funding statement. The correct numbers for the “National Program Project” are “Grants 2018ZX10731301-006-001 (HS/SPH), 2013ZX10003009-002 (HS/IPS).” The correct number for the “Clinical Research Plan of SHDC” is “16CR1028B (WS/SPH),” and the correct numbers for the National Institutes of Health R01 grants are “OD015092/RR13601, HL64560, and HL129887 (ZC).”

A correction has therefore been made to the Funding statement:

“This work was supported by the National Program Project Grants 2018ZX10731301-006-001 (HS/SPH), 2013ZX10003009-002 (HS/IPS), Clinical Research Plan of SHDC 16CR1028B (WS/SPH), and the National Institutes of Health R01 grants OD015092/RR13601, HL64560, and HL129887 (ZC).”

The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: IL-12, Vγ2Vδ2 T cells, proliferation, differentiation, anti-tuberculosis

Citation: Yang R, Yao L, Shen L, Sha W, Modlin RL, Shen H and Chen ZW (2019) Corrigendum: IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth. Front. Immunol. 10:1742. doi: 10.3389/fimmu.2019.01742

Received: 10 July 2019; Accepted: 10 July 2019;
Published: 26 July 2019.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Yang, Yao, Shen, Sha, Modlin, Shen and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wei Sha, shfksw@126.com; Hongbo Shen, hongboshen109@hotmail.com